Truvada emtricitabine/tenofovir regulatory update

FDA's Antiviral Drugs Advisory Committee will meet on May 10 to discuss an sNDA from Gilead for Truvada emtricitabine/tenofovir for pre-exposure prophylaxis (PrEP) to reduce risk of HIV-1 infection in...